miR-338-3p suppresses the malignancy of T-cell lymphoblastic lymphoma by downregulating HOXA3

T-cell lymphoblastic lymphoma (T-LBL) is an aggressive malignancy with poor prognosis due to frequent relapses. Previous studies have reported an association of the disease with abnormal chromosomal rearrangements, DNA copy number alterations and mutations in critical signaling factors, such as thos...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Sui, Minghua, Wang, Xiuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691266/
https://www.ncbi.nlm.nih.gov/pubmed/31322185
http://dx.doi.org/10.3892/mmr.2019.10451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691266/
https://www.ncbi.nlm.nih.gov/pubmed/31322185
http://dx.doi.org/10.3892/mmr.2019.10451

Ejemplares similares